CME Buys Elysian for OTC Drive

CME Group last week acquired UK-based trading and market data software vendor Elysian Systems to extend its services for OTC derivatives markets. Elysian currently provides desktop data display, analytics and trading terminals to more than 1,400 end-users at over 200 bank, broker and exchange clients around the world, and CME plans to combine this technology with its ClearPort OTC clearing service.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: